Glutathione-Responsive Polyhomocysteine Derivatives with Ultralow Toxicity toward Therapeutic Delivery
Biomacromolecules · 2025
DOI: 10.1021/acs.biomac.5c01014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2025. Verfasst von Bowen Zhao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Miami, 1301 Memorial Drive, Coral Gables, Florida 33146, United States. Hauptthemen laut MEDLINE: Glutathione, Homocysteine, Drug Delivery Systems, Peptides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: NCI NIH HHS, National Cancer Institute, Sylvester Comprehensive Cancer Center, University of Miami Health Systems.
Abstract (Originalsprache)
Disulfide-containing synthetic polypeptides hold significant promise as biodegradable and biocompatible carriers for controlled drug and gene delivery, enabling triggered therapeutic release with reduced cytotoxicity. However, disulfide incorporation remains challenging, whether through direct polymerization of disulfide-containing monomers or postpolymerization modification. In this work, we present an innovative and simple strategy to incorporate disulfide bonds into polypeptides using ring-opening polymerization of the N-carboxyanhydride of homocysteine, a thiol-containing amino acid. The polymerization was well-controlled, yielding repeating units up to 100 with narrow dispersity. The pendant side chains were readily converted into various GSH-responsive moieties, including anionic, neutral, zwitterionic, and cationic groups, as well as therapeutic agents toward a wide range of biomedical applications. The drug-loaded amphiphilic polymer-drug conjugates displayed triggered release of intact drug and potent anticancer activities. Furthermore, cationic polyhomocysteine derivatives effectively delivered siRNA, eGFP mRNA, and more complex CRISPR components with extremely low cytotoxicity and excellent transfection efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Miami, 1301 Memorial Drive, Coral Gables, Florida 33146, United States.
- Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida 33136, United States.
- Department of Pathology and Laboratory Medicine, Miller School of Medicine, University of Miami, Miami, Florida 33136, United States.
- Department of Molecular and Cellular Pharmacology, Miller School of Medicine, University of Miami, Miami, Florida 33136, United States.
- The Dr. John T. Macdonald Foundation Biomedical Nanotechnology Institute, University of Miami, Miami, Florida 33136, United States.
ORCID-Profile: Shiwei Fu, Ivan O Levkovsky, Jonah G Ferber, Fuwu Zhang
Förderung
- NCI NIH HHS
- National Cancer Institute
- Sylvester Comprehensive Cancer Center, University of Miami Health Systems
- National Science Foundation
- University of Miami
Zitieren
APA
Zhao, B., Zhang, X., Bilbao, D., Satta, S., Steele, N. S., Chen, J., Fu, S., Bickle, M. S., Gu, J., Levkovsky, I. O., Ruiz, E. F., Ferber, J. G., & Zhang, F. (2025). Glutathione-Responsive Polyhomocysteine Derivatives with Ultralow Toxicity toward Therapeutic Delivery. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c01014
Vancouver
Zhao B, Zhang X, Bilbao D, Satta S, Steele NS, Chen J, et al. Glutathione-Responsive Polyhomocysteine Derivatives with Ultralow Toxicity toward Therapeutic Delivery. Biomacromolecules. 2025. doi:10.1021/acs.biomac.5c01014
BibTeX
@article{Zhao2025,
author = {Zhao, Bowen and Zhang, Xiao and Bilbao, Daniel and Satta, Sandro and Steele, Nicholas S and Chen, Jiuyan and Fu, Shiwei and Bickle, Molly S and Gu, Jun and Levkovsky, Ivan O and Ruiz, Elena F and Ferber, Jonah G and Zhang, Fuwu},
title = {Glutathione-Responsive Polyhomocysteine Derivatives with Ultralow Toxicity toward Therapeutic Delivery},
journal = {Biomacromolecules},
year = {2025},
doi = {10.1021/acs.biomac.5c01014}
}
EUVIMED